BMS Outlines Clinical Trial Disruptions, Reassures Supply Chain Secure

 
• By Jessica Merrill

The company is the latest big pharma to announce clinical trial delays due to the COVID-19 pandemic and has postponed an R&D day, but it also delivered the message that supply and commercial operations appear on track.

Posponed blocks
Bristol says new clinical trial starts will be delayed • Source: Shutterstock

More from Clinical Trials

More from R&D